Friday, July 10, 2026

pharma · Malignant Pleural Mesothelioma · Bipolar I Depression

Sumitomo Pharma Co

Sumitomo Pharma Co trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

JP HQ
1897 Founded
193 Employees
NMPA registrant Type
Company details
Status
Public
HQ
JP
Founded
1897
Employees
193
Programs
4
Drugs
3
Patents
0
Intelligence · Clinical Trials

Sumitomo Pharma Co clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Sumitomo Pharma Co programs — each row shows trial ID, program name, phase, status, and indication.

Sumitomo Pharma Co trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Sumitomo Pharma Co.

  1. BBI608 — Phase 2

    Clinical update
  2. Lurasidone — Phase 3

    Clinical update
  3. Napabucasin — Phase 3

    Clinical update
  4. Placebo — Phase 3

    Clinical update

Trial registry

4 studies